Trial intelligence / Profile preview

Exhaled breath biosensor patterns in healthy and asthmatic children and the effects of montelukast and fluticasone

2007-000891-17Phase 4Terminated

Sponsor
Policlinico Gemelli
Start
Apr 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4 trial of montelukast and fluticasone propionate in asthma (3 arms), sponsored by Policlinico Gemelli. Primary endpoint: Concentrations of exhaled nitric oxide. Started Apr 2007; status: terminated.

02

Drugs

montelukastfluticasone propionate
03

Conditions

asthma

Beyond the preview

Go deeper on 2007-000891-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-000891-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call